Retinal Vasoproliferative Tumours in Uveitis
PURPOSE: To describe a cohort of patients with retinal vasoproliferative tumours (RVPT) seen in the uveitis clinic of a single tertiary eye care institute in India.
METHODS: Retrospective Chart Review.
RESULTS: In our study of 17 patients with 18 eyes affected by RVPTs, 94.1% showed unilateral involvement, one patient had bilateral RVPTs, and another had two RVPTs in the same eye. The mean age was 36.3 ± 15.1 years (range: 12-63 years), with a male majority (76.4%). The most common location was inferotemporal quadrant (44.4%). The most common associated uveitic condition was intermediate uveitis (50%). Patients were treated with oral corticosteroid (in 94.1%) and immunosuppressive (35.2%) in addition to transconjunctival cryotherapy (in 52.9%) or laser photocoagulation (in 41.1%). Regression of the RVPT was achieved in all cases except one. Visual acuity at time of detection of RVPT ranged from 6/6 to HM. No significant change was noted in the mean best corrected visual acuity pre and post treatment in the study group.
CONCLUSION: RVPTs, rare peripheral retinal lesions often associated with intermediate uveitis, require early diagnosis with targeted therapy to prevent vision loss and achieve favorable long-term outcomes with rare recurrences.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - (2024) vom: 29. Feb., Seite 1-5 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmed, Arshee S [VerfasserIn] |
---|
Links: |
---|
Themen: |
Immunosuppressives |
---|
Anmerkungen: |
Date Revised 05.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1080/09273948.2024.2317418 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36911857X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36911857X | ||
003 | DE-627 | ||
005 | 20240305232505.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240301s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2024.2317418 |2 doi | |
028 | 5 | 2 | |a pubmed24n1317.xml |
035 | |a (DE-627)NLM36911857X | ||
035 | |a (NLM)38421940 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ahmed, Arshee S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Retinal Vasoproliferative Tumours in Uveitis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 05.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a PURPOSE: To describe a cohort of patients with retinal vasoproliferative tumours (RVPT) seen in the uveitis clinic of a single tertiary eye care institute in India | ||
520 | |a METHODS: Retrospective Chart Review | ||
520 | |a RESULTS: In our study of 17 patients with 18 eyes affected by RVPTs, 94.1% showed unilateral involvement, one patient had bilateral RVPTs, and another had two RVPTs in the same eye. The mean age was 36.3 ± 15.1 years (range: 12-63 years), with a male majority (76.4%). The most common location was inferotemporal quadrant (44.4%). The most common associated uveitic condition was intermediate uveitis (50%). Patients were treated with oral corticosteroid (in 94.1%) and immunosuppressive (35.2%) in addition to transconjunctival cryotherapy (in 52.9%) or laser photocoagulation (in 41.1%). Regression of the RVPT was achieved in all cases except one. Visual acuity at time of detection of RVPT ranged from 6/6 to HM. No significant change was noted in the mean best corrected visual acuity pre and post treatment in the study group | ||
520 | |a CONCLUSION: RVPTs, rare peripheral retinal lesions often associated with intermediate uveitis, require early diagnosis with targeted therapy to prevent vision loss and achieve favorable long-term outcomes with rare recurrences | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Retinal vasoproliferative tumours | |
650 | 4 | |a immunosuppressives | |
650 | 4 | |a intermediate uveitis | |
650 | 4 | |a steroid | |
700 | 1 | |a Dutta Majumder, Parthopratim |e verfasserin |4 aut | |
700 | 1 | |a Elizabeth, Amala |e verfasserin |4 aut | |
700 | 1 | |a Rao, Vinita |e verfasserin |4 aut | |
700 | 1 | |a Ganesh, Sudha |e verfasserin |4 aut | |
700 | 1 | |a Biswas, Jyotirmay |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g (2024) vom: 29. Feb., Seite 1-5 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:29 |g month:02 |g pages:1-5 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2024.2317418 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 29 |c 02 |h 1-5 |